D-(-)-3-methoxyphenylglycine | 25698-23-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: D-(-)-3-methoxyphenylglycine
• 英文别名: (R)-3-methoxyphenylglycine；D-(3-methoxyphenyl)glycine；D-m-Methoxy-phenylglycin；D-3-Methoxyphenylglycin；(2R)-2-azaniumyl-2-(3-methoxyphenyl)acetate
• CAS: 25698-23-1
• 化学式: C₉H₁₁NO₃
• mdl: MFCD02662407
• 分子量: 181.191
• InChiKey: UMKVNPOZWRHJPM-MRVPVSSYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.7
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  5-(3-Methoxyphenyl)imidazolidine-2,4-dione 在 盐酸 、 Tris-HCl buffer 、 manganese(ll) chloride 、 sodium nitrite 作用下， 反应 49.0h， 生成 D-(-)-3-methoxyphenylglycine
  参考文献：
  名称：

  Production of ring-substituted D-phenylglycines by microbial or enzymatic hydrolysis/deracemisation of the corresponding DL-hydantoins

  摘要：

  A series of 17 ring-mono and -disubstituted D-phenylglycine derivatives was prepared in high enantiomeric purity by enzymatic hydrolysis and deracemisation of the corresponding DL-hydantoins, using D-hydantoinase activities of microorganisms or purified enzymes, followed by diazotation of the resulting N-carbamyl D-amino acids. No significant L-hydantoinase activity was found to produce the corresponding L-enantiomers. (C) 1997, Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(96)00488-0

文献信息

• One-Pot Enantioselective Synthesis of <scp>d</scp> -Phenylglycines from Racemic Mandelic Acids, Styrenes, or Biobased <scp>l</scp> -Phenylalanine <i>via</i> Cascade Biocatalysis
  作者：Yi Zhou、Shuke Wu、Zhi Li

  DOI：10.1002/adsc.201700956

  日期：2017.12.19

  enantiopure d‐phenylglycine in 80% conversion via a one‐pot 6‐step cascade biotransformation. Twelve substituted d‐phenylglycines were also produced from the corresponding styrene derivatives in high conversion (45–90%) and very high ee (92–99%) via the same cascade reactions. A nine‐enzymeexpressing E. coli (LZ143) was engineered to transform biobased l‐phenylalanine to enantiopure d‐phenylglycine

  对映纯d-苯基甘氨酸及其衍生物是重要的一组手性氨基酸，在制药工业中具有广泛的应用。但是，现有的d-苯基甘氨酸合成方法主要依靠有毒的氰化物化学和多步法。为了提供绿色和安全的替代品，我们设想了级联生物催化，分别由外消旋扁桃酸，苯乙烯和生物基1-苯基丙氨酸一锅法合成d-苯基甘氨酸。重组大肠杆菌（LZ110）被设计为在一个锅中共表达四种酶以催化三步反应，将扁桃酸（210 mM）转化为29.5 g L -1的对映体纯的d-苯基甘氨酸（195 mM），转换率达93％。使用相同的全细胞催化剂，还可以由相应的扁桃酸衍生物以高转化率（58-94％）和非常高ee（93-99％）的方式生产其他十二种d-苯基甘氨酸衍生物。构建了表达7种酶的大肠埃希氏菌（LZ116），可通过一锅6步级联生物转化法将苯乙烯转化为对映体纯的d-苯基甘氨酸，转化率为80％。通过相同的级联反应，十二种取代的d-苯基甘氨酸也从相应的苯乙烯衍
• RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF
  申请人：The Johns Hopkins University

  公开号：US20210094933A1

  公开（公告）日：2021-04-01

  The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.

  本公开提供了受免疫蛋白配体家族FK506和雷帕霉素天然产物启发的大环化合物。生成包含FK506和雷帕霉素结合结构域的Rapafucin大环化合物库，应具有作为治疗疾病新药的潜力。
• Practical and Convenient Enzymatic Synthesis of Enantiopure α-Amino Acids and Amides
  作者：Mei-Xiang Wang、Shuang-Jun Lin

  DOI：10.1021/jo0256282

  日期：2002.9.1

  enantioselectivity was also discussed in terms of steric and electronic effects. Coupled with chemical hydrolysis of D-(-)-alpha-phenylglycine amide, biotransformation of DL-phenylglycine nitrile was applied in practical scale to produce both D- and L-phenylglycines in high optical purity.

  在红球菌属中被腈水合酶和酰胺酶催化。AJ270细胞在非常温和的条件下，许多α-芳基-和α-烷基取代的DL-甘氨酸腈1迅速经历高度对映选择性水解，从而得到D-（-）-α-氨基酸酰胺2和L-（+ ）-α-氨基酸3的收率很高，多数情况下对映异构体过量。腈类生物转化的总体对映选择性源于高L-对映选择性酰胺酶和低对映选择性腈水合酶的综合作用。还在空间和电子效应方面讨论了底物对反应效率和对映选择性的影响。加上D-（-）-α-苯基甘氨酸酰胺的化学水解，
• A new asymmetric transformation of α-amino-acid esters with (+)-tartaric acid
  作者：John C. Clark、Gordon H. Phillipps、Margaret R. Steer

  DOI：10.1039/p19760000475

  日期：——

  Esters of DL-phenylglycine or substituted phenylglycines, on being stirred with (+)-tartaric acid in alcohols in the presence of carbonyl compounds, give, depending on the reaction conditions, the D- or L-ester hydrogen (+)-tartrates in up to nearly 100% yield (i.e. almost all the racemic ester is converted into the D- or L-salt). The mechanism of this new type of asymmetric transformation is discussed

  DL-苯基甘氨酸或取代的苯基甘氨酸的酯，在羰基化合物存在下与（+）-酒石酸在醇中搅拌时，根据反应条件，可得到D-或L-酯氢（+）-酒石酸收率接近100％（即几乎所有的外消旋酯都转化为D-或L-盐）。讨论了这种新型的不对称变换的机制。的d -或大号-酯氢（+） -酒石酸盐是由强酸或强碱，得到高光学纯度的氨基酸水解。
• Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors
  申请人：Allen George David

  公开号：US20070111995A1

  公开（公告）日：2007-05-17

  The invention provides pyrazolo[3,4-b]pyridine compounds of formula (I) having a —C(O)—NH—C(R 4 )(R 5 )-aryl substituent at the 5-position of the pyrazolo[3,4-b]pyridine ring system wherein at least one of R 4 and R 5 is not a hydrogen atom (H) compound or a salt thereof: wherein Ar has the sub-formula (x) or (z). These compounds are useful as inhibitors of PDE4.

  本发明提供了式(I)的吡唑并[3,4-b]吡啶化合物，其在吡唑并[3,4-b]吡啶环系的5位具有—C(O)—NH—C(R4)(R5)-芳基取代基，其中R4和R5中至少有一个不是氢原子（H）化合物或其盐：其中Ar具有亚式（x）或（z）。这些化合物可用作PDE4的抑制剂。